News Focus
News Focus
icon url

hoffmann6383

04/14/23 3:17 PM

#585492 RE: exwannabe #585488

False.

Provenge

November 13, 2006 was first BLA submission.

April 29, 2010 was the approval.

Provenge days from BLA filing till approval: 1,263 days

^^ That doesn't even include the days from data lock to BLA submission.

Your timelines are misleading, at best.

https://www.drugs.com/history/provenge.html
Bullish
Bullish
icon url

dstock07734

04/14/23 3:26 PM

#585498 RE: exwannabe #585488

EX,

"I wanted as much to initiate a cancer immune response as I wanted to initiate one against infection."

This is what Dr. Steinman would love to see. Now NWBO has made his dream a reality. Dr. Liau said that in combo trial the immune response from patients was so drastic that patients had to go through surgery.

It is good news for all the investors.
icon url

Arby2000

04/14/23 3:31 PM

#585503 RE: exwannabe #585488

They tried to get approved based on a P2 that failed the primary endpoint of PFS but was stat sig on the secondary endpoint of OS. The FDA said that is no good and they needed a real P3 trial that properly defined the prospective OS endpoint in advance.



I think there have been a few changes in FDA's thinking since 2009.